150 related articles for article (PubMed ID: 35535222)
21. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
22. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
[TBL] [Abstract][Full Text] [Related]
23. The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats.
Wen RT; Zhang M; Qin WJ; Liu Q; Wang WP; Lawrence AJ; Zhang HT; Liang JH
Alcohol Clin Exp Res; 2012 Dec; 36(12):2157-67. PubMed ID: 22671516
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
[TBL] [Abstract][Full Text] [Related]
25. Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model.
Yeo CD; Kim JW; Ha JH; Kim SJ; Lee SH; Kim IK; Kim YK
Exp Lung Res; 2014 Dec; 40(10):500-6. PubMed ID: 25275945
[TBL] [Abstract][Full Text] [Related]
26. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses.
Zhou ZZ; Cheng YF; Zou ZQ; Ge BC; Yu H; Huang C; Wang HT; Yang XM; Xu JP
ACS Chem Neurosci; 2017 Jan; 8(1):135-146. PubMed ID: 27690383
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.
Tavares LP; Garcia CC; Vago JP; Queiroz-Junior CM; Galvão I; David BA; Rachid MA; Silva PM; Russo RC; Teixeira MM; Sousa LP
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):24-34. PubMed ID: 26677751
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs.
Mokry J; Joskova M; Mokra D; Christensen I; Nosalova G
Adv Exp Med Biol; 2013; 756():57-64. PubMed ID: 22836619
[TBL] [Abstract][Full Text] [Related]
29. Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice.
Atkins CM; Cepero ML; Kang Y; Liebl DJ; Dietrich WD
Neurosci Lett; 2013 Jan; 532():1-6. PubMed ID: 23103712
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation.
Wollborn J; Siemering S; Steiger C; Buerkle H; Goebel U; Schick MA
Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H751-H761. PubMed ID: 30681364
[TBL] [Abstract][Full Text] [Related]
31. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
[TBL] [Abstract][Full Text] [Related]
32. Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats.
Li LX; Cheng YF; Lin HB; Wang C; Xu JP; Zhang HT
Metab Brain Dis; 2011 Mar; 26(1):37-47. PubMed ID: 21327879
[TBL] [Abstract][Full Text] [Related]
33. Rolipram promotes functional recovery after contusive thoracic spinal cord injury in rats.
Costa LM; Pereira JE; Filipe VM; Magalhães LG; Couto PA; Gonzalo-Orden JM; Raimondo S; Geuna S; Maurício AC; Nikulina E; Filbin MT; Varejão AS
Behav Brain Res; 2013 Apr; 243():66-73. PubMed ID: 23295392
[TBL] [Abstract][Full Text] [Related]
34. Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity.
Mondal D; Bagchi A; Biswas S; Dagar T; Biswas A; Bagchi A; De S
ACS Appl Bio Mater; 2024 Jan; 7(1):369-378. PubMed ID: 38150107
[TBL] [Abstract][Full Text] [Related]
35. PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis.
Wiescholleck V; Manahan-Vaughan D
Transl Psychiatry; 2012 Mar; 2(3):e89. PubMed ID: 22832854
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Galindo-Tovar A; Kaumann AJ
Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
[TBL] [Abstract][Full Text] [Related]
37. Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study.
Fang CL; Wen CJ; Aljuffali IA; Sung CT; Huang CL; Fang JY
J Control Release; 2015 Sep; 213():69-78. PubMed ID: 26164036
[TBL] [Abstract][Full Text] [Related]
38. Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways.
Maher A; El Sayed N; Nafea H; Gad M
CNS Neurol Disord Drug Targets; 2022; 21(7):631-639. PubMed ID: 34397335
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
[TBL] [Abstract][Full Text] [Related]
40. The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway.
Dong XL; Wang YH; Xu J; Zhang N
Sci Rep; 2021 Oct; 11(1):19737. PubMed ID: 34611179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
